Spellmann, Ilja http://orcid.org/0000-0002-3041-2386
Reinhard, Matthias A.
Veverka, Diana
Zill, Peter
Obermeier, Michael
Dehning, Sandra
Schennach, Rebecca
Müller, Norbert
Möller, Hans-Jürgen
Riedel, Michael
Musil, Richard
Article History
Received: 7 August 2017
Accepted: 4 February 2018
First Online: 10 February 2018
Compliance with ethical standards
:
: The authors declare that over the past three years Author Dr. R. Musil has received research support from Janssen-Cilag, Speaker Honoraria from Otsuka and has been on the advisory board of Roche Pharmaceuticals, author Prof. Dr. M. Riedel has received grants/research support from AstraZeneca and Pfizer and is speaker or in the advisory board of AstraZeneca, Pfizer, Bristol-Meyers-Squibb, Otsuka and Servier. These affiliations have no relevance to the work covered in the manuscript. On behalf of all authors, the corresponding author states that there is no conflict of interest.